-2%
Rapasin 8, an alpha-adrenergic antagonist, is employed in the management of benign prostatic hyperplasia. It aids in alleviating symptoms such as difficulty urinating. However, it doesn’t reduce the prostate’s size.Â
- Highly effective for BPH treatment.
- Offers high uroselectivity for alpha-1 adrenergic receptors.
- Serves as an alternative for patients unresponsive to Tamsulosin.
- Does not cause orthostatic hypotension.
- Convenient once-daily dosing.
- Always take a registered physician’s advice.
Rapasin is prescribed for the treatment of signs and symptoms of benign prostatic hyperplasia (BPH). It is not intended for the management of hypertension.
Silodosin, the active ingredient in Rapasin, is a selective antagonist of post-synaptic alpha-1 adrenoreceptors found in the prostate, bladder base, bladder neck, prostatic capsule, and prostatic urethra. By blocking these receptors, Rapasin induces smooth muscle relaxation, leading to improved urine flow and reduced BPH symptoms.